⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TAK News
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Tim Foley Joins Deep Origin as Chief Commercial Officer
globenewswire.com
TAK
ALM
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care
businesswire.com
TAK
1日1回投与の利便性を備えた経口薬であるザソシチニブによる、迅速かつ持続的な皮膚症状の改善効果および乾癬治療を変革する可能性を示唆した臨床試験結果の発表について
businesswire.com
TAK
Plasma Fractionation Market to Reach USD 51.06 Billion by 2032, Driven by Rising Demand for Immunoglobulins and Growing Prevalence of Immune Disorders | MarkNtel Advisors
prnewswire.com
CSL
TAK
Belief BioMed announced BBM-H901 (Dalnacogene Ponparvovec Injection), China's first hemophilia B gene therapy, was officially approved in Macao, China USA - English APAC - Traditional Chinese
prnewswire.com
TAK
Samsung Bioepis Enters into Partnership Agreement with Sandoz for Up to Five Next-Generation Biosimilar Candidates
businesswire.com
TAK
Rixubis (Takeda Pharmaceutical) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
TAK
PFE
Trialbee Appoints Accomplished Life Sciences Executive Rick Riegel to Board of Directors to Accelerate Global Patient Recruitment for Clinical Trials
businesswire.com
BMY
SNY
TAK
LLY
Feiba NF (Takeda Pharmaceuticals) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, & Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
TAK
Feiba VH (Takeda Pharmaceuticals) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, & Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
TAK
PFE